Metvixia side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Metvixia. Common side effects include burns second degree among females and keratitis among males.

The phase IV clinical study is created by eHealthMe based on 49 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 07, 2022

49 people who take Metvixia and have side effects are studied.


What is Metvixia?

Metvixia has active ingredients of methyl aminolevulinate hydrochloride. eHealthMe is studying from 49 Metvixia users for its effectiveness, alternative drugs and more.

Number of Metvixia reports submitted per year:

Metvixia side effects.

Metvixia side effects by time on the drug*:

< 1 month:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Cheilitis (infection of lips)
  3. Corneal disorder
  4. Corneal erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying)
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  8. Eye swelling
  9. Hypertension (high blood pressure)
  10. Keratitis (eye's cornea, the front part of the eye, becomes inflamed)

1 - 6 months:

  1. Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
  2. Metastases to liver (cancer spreads to liver)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Hypertensive crisis
  2. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  3. Asthma
  4. Atypical fibroxanthoma (atypical fibroxanthoma of the skin is a low-grade malignancy related to malignant fibrous histiocytoma)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Gastrointestinal carcinoma (cancer of stomach or intestine)
  7. Keratitis (eye's cornea, the front part of the eye, becomes inflamed)
  8. Metastases to liver (cancer spreads to liver)
  9. Neoplasm malignant (cancer tumour)
  10. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)

Metvixia side effects by gender *:

female:

  1. Burns second degree
  2. Skin test positive
  3. Anxiety
  4. Application site pustules (small bumps on the skin that fill with fluid or pus at application site)
  5. Asthma
  6. Blepharitis (chronic inflammation of the eyelid)
  7. Blood creatine increased
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Cheilitis (infection of lips)
  10. Corneal disorder

male:

  1. Keratitis (eye's cornea, the front part of the eye, becomes inflamed)
  2. Metastases to liver (cancer spreads to liver)
  3. Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
  4. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  5. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  6. Angioedema (rapid swelling of the dermis)
  7. Atypical fibroxanthoma (atypical fibroxanthoma of the skin is a low-grade malignancy related to malignant fibrous histiocytoma)
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Corneal erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying)
  10. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

Metvixia side effects by age (0-1 to 60+) *:

0-1:

  1. Keratitis (eye's cornea, the front part of the eye, becomes inflamed)

2-9:

  1. Skin lesion

10-19:

n/a

20-29:

  1. Burns second degree

30-39:

  1. Blepharitis (chronic inflammation of the eyelid)
  2. Skin oedema (swelling of skin)

40-49:

  1. Application site pustules (small bumps on the skin that fill with fluid or pus at application site)
  2. Cheilitis (infection of lips)
  3. Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)

50-59:

  1. Corneal erosion (failure of the cornea's outermost layer of epithelial cells to attach to the underlying)
  2. Erythema (redness of the skin)
  3. Squamous cell carcinoma (a cancer of a kind of epithelial cell)

60+:

  1. Angioedema (rapid swelling of the dermis)
  2. Asthma
  3. Atypical fibroxanthoma (atypical fibroxanthoma of the skin is a low-grade malignancy related to malignant fibrous histiocytoma)
  4. Blood creatine increased
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Corneal disorder
  7. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  8. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  10. Erythema (redness of the skin)

* Approximation only. Some reports may have incomplete information.

Do you take Metvixia?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on methyl aminolevulinate hydrochloride (the active ingredients of Metvixia) and Metvixia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Metvixia:

All Metvixia side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: